Epigenetic Clock: Just a Convenient Marker or an Active Driver of Aging?
Level 5 - mechanism / opinion, no new human data
Narrative review and theoretical mechanism discussion without systematic search or new human data
PubMed 31493228 · doi:10.1007/978-3-030-25650-0_10
What was done
This narrative review synthesizes mammalian evidence on age-associated DNA methylation changes, comparing stochastic epigenetic drift with predictable locus-specific alterations used in epigenetic clocks, and examines whether these changes act as causal drivers or passive markers of aging.
What was found
The abstract reports no numerical values or quantitative effect estimates. It outlines qualitative biological patterns: global DNA hypomethylation primarily targeting repetitive transposable elements, paired with locus-specific promoter hypermethylation at CpG islands and hypomethylation in CpG-poor regions. Methylation across specific CpG sites correlates with age and forms clocks where discrepancy with chronological age predicts all-cause mortality and age-associated disease. The review also notes that accumulating epigenetic drift increases cell-to-cell transcriptional noise, driving organ decline, while emphasizing that epigenetic aging states remain potentially reversible.
Why it matters
It highlights that epigenetic aging markers are not only predictive tools for mortality and disease risk, but represent potentially reversible mechanisms underlying functional decline in tissues.
Limits
As a non-systematic narrative review, it presents no primary data, sample sizes, or quantitative confidence intervals. The abstract discusses broad biological mechanisms without defining specific effect sizes or resolving whether observed clock correlations reflect direct causality in human aging.
Cited by
- supports With aging, genomic CpG sites that typically have methylation lose it, while CpG sites that typically lack methylation gain it.